Compile Data Set for Download or QSAR
Report error Found 125 Enz. Inhib. hit(s) with all data for entry = 11993
TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668573(US11964949, Compound OTB-261)
Affinity DataIC50: 2.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668521(US11964949, Compound OTB-407)
Affinity DataIC50: 3.08E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668523(US11964949, Compound OTB-408)
Affinity DataIC50: 3.61E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668574(US11964949, Compound OTB-523)
Affinity DataIC50: 4.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668566(US11964949, Compound OTB-509)
Affinity DataIC50: 5.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668620(US11964949, Compound OBD-048)
Affinity DataIC50: 5.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668559(US11964949, Compound OTB-510)
Affinity DataIC50: 5.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668611(US11964949, Compound OBD-051)
Affinity DataIC50: 6.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668592(US11964949, Compound OTB-244)
Affinity DataIC50: 6.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668621(US11964949, Compound OBD-049)
Affinity DataIC50: 6.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668579(US11964949, Compound OTB-249)
Affinity DataIC50: 7.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668617(US11964949, Compound OBD-111)
Affinity DataIC50: 7.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668616(US11964949, Compound OBD-110)
Affinity DataIC50: 7.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668538(US11964949, Compound OTB-120)
Affinity DataIC50: 7.27E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668531(US11964949, Compound OBD-006)
Affinity DataIC50: 7.49E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668528(US11964949, Compound OTB-137)
Affinity DataIC50: 7.64E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668557(US11964949, Compound OTB-506)
Affinity DataIC50: 8.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668565(US11964949, Compound OTB-508)
Affinity DataIC50: 8.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668524(US11964949, Compound OTB-409)
Affinity DataIC50: 8.51E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668525(US11964949, Compound OTB-411)
Affinity DataIC50: 8.73E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668563(US11964949, Compound OTB-511)
Affinity DataIC50: 9.00E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668520(US11964949, Compound OTB-413)
Affinity DataIC50: 9.13E+3nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668519(US11964949, Compound OTB-412)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668578(US11964949, Compound OTB-247)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668581(US11964949, Compound OTB-250 | US11964949, Compoun...)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668580(US11964949, Compound OTB-255)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668558(US11964949, Compound OTB-507)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668587(US11964949, Compound OTB-253)
Affinity DataIC50: 1.00E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668527(US11964949, Compound OTB-127)
Affinity DataIC50: 1.02E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668540(US11964949, Compound OBD-001)
Affinity DataIC50: 1.20E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668567(US11964949, Compound OTB-513)
Affinity DataIC50: 1.30E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668555(US11964949, Compound OBD-016)
Affinity DataIC50: 1.30E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668612(US11964949, Compound OBD-052)
Affinity DataIC50: 1.30E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668604(US11964949, Compound OTB-230)
Affinity DataIC50: 1.30E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668549(US11964949, Compound OTB-502)
Affinity DataIC50: 1.36E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668590(US11964949, Compound OTB-243)
Affinity DataIC50: 1.40E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668613(US11964949, Compound OBD-055)
Affinity DataIC50: 1.50E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668546(US11964949, Compound OTB-227)
Affinity DataIC50: 1.52E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668584(US11964949, Compound OTB-516)
Affinity DataIC50: 1.53E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668516(US11964949, Compound OBD-005)
Affinity DataIC50: 1.56E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668543(US11964949, Compound OBD-004)
Affinity DataIC50: 1.58E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668551(US11964949, Compound OTB-504)
Affinity DataIC50: 1.70E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668598(US11964949, Compound OBD-056)
Affinity DataIC50: 1.70E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668585(US11964949, Compound OTB-520)
Affinity DataIC50: 1.70E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668575(US11964949, Compound OTB-515)
Affinity DataIC50: 1.75E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668539(US11964949, Compound OTB-121)
Affinity DataIC50: 1.76E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668624(US11964949, Compound OBD-054)
Affinity DataIC50: 1.85E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668553(US11964949, Compound OTB-237)
Affinity DataIC50: 1.90E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668532(US11964949, Compound OBD-007)
Affinity DataIC50: 1.98E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

TargetCytochrome c oxidase subunit 1(Human)
The Global Alliance For Tb Drug Development

US Patent
LigandPNGBDBM668577(US11964949, Compound OTB-241)
Affinity DataIC50: 1.98E+4nMAssay Description:H9C2 cells were incubated in DMEM (Hyclone, GE LifeSciences) with 10% FBS (Gibco, Life Technologies) and 1 Glutamine (Gibco, Life Technologies) and N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
US Patent

Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: